Examples of Mediclinic Shareholders in a sentence
Mediclinic Shareholders resident in Japan, or who hold Mediclinic Shares as custodian or nominee for, or otherwise on behalf of, persons resident in Japan, may not elect for the Repurchase Option in relation to such Mediclinic Shares.
It should be noted that one of the conditions of the Scheme is that within 30 Business Days following the Scheme Meeting, Mediclinic Shareholders either do not validly exercise Appraisal Rights, or they validly exercise Appraisal Rights in terms of section 164 of the Companies Act by giving valid demands in terms of section 164(7) of the Companies Act, in respect of no more than 3% of the issued ordinary shares of Mediclinic.
Scheme Participants who are Qualifying SA Corporates will be deemed to have elected the Repurchase Option, provided that all Scheme Participants are, however, entitled to make an election in respect of all or any of their Scheme Shares except that Mediclinic Shareholders resident in Japan, or who hold Mediclinic Shares as custodian or nominee for, or otherwise on behalf of, persons resident in Japan, may not elect for the Repurchase Option in relation to such Mediclinic Shares.
Mediclinic Shareholders who are in doubt as to their position should consult their professional advisors immediately.
Mediclinic Shareholders who believe they may be affiliates for the purposes of the Securities Act should consult their own legal advisers.
Mediclinic Shareholders who are affiliates of Al Noor after the Scheme will be subject to timing, manner of sale and volume restrictions on the sale of New Shares received pursuant to the Scheme under Rule 144 under the Securities Act.
The Independent Expert has prepared a report in terms of section 114 of the Companies Act and Regulation 90 of the Companies Regulations on the fairness and reasonableness of the Assets Transfer and the Scheme in so far as Mediclinic Shareholders are concerned, a copy of which is annexed hereto as Annexure 8.
Taking into consideration the terms and conditions of the Scheme, the Independent Expert is of the opinion that such terms and conditions are fair and reasonable to Mediclinic Shareholders.
Mediclinic Shareholders are advised that no dematerialisation or rematerialisation of Mediclinic Shares may take place after the Scheme Last Day to Trade.
The Scheme must be approved by a special resolution, in accordance with section 115(2)(a) of the Companies Act, at the Scheme Meeting, at which at least three Mediclinic Shareholders are present or represented by proxy and sufficient Scheme Members are present to exercise, in aggregate, at least 25% of all the voting rights that are entitled to be exercised at the Scheme Meeting.